UNH — UnitedHealth Group Incorporated Common Stock (DE) stock price and chart

UNH

$410.39-0.08%

as of close, Oct 27, 2026

☾ AH $410.39 -0.08%

UnitedHealth Group Incorporated Common Stock (DE)Stock · HealthcareDow Jones · 4.7% of DIAS&P 500 · 0.6% of SPYRussell 1000 · 0.5% of IWBUS Stock Market · 0.5% of VTIRussell 3000 · 0.5% of IWVMSCI World · 0.4% of URTHMSCI ACWI · 0.4% of ACWIS&P 500 Equal Weight · 0.2% of RSP

PeersCVSELVHUMCICNCJNJ

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDE

20162019202120242026

150.0200.0250.0300.0350.0400.0450.0500.0550.0600.00100.0M200.0M$410.39

2026-10-27

Price$410.39

MA20$400.54

MA50$355.41

Vol17.6M

What would $1,000 invested in UNH be worth today? →

UNH returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $410.39
YTD price return: +24.32%
YTD total return: +26.78%
Market cap: 368.4B2016-12 152.3B2026-10 368.6B+142.0% over the window
Enterprise value: 420.9B
Shares outstanding: 897.6M2016-06 952.4M2026-06 897.6M-5.8% over the window
52W low: $255.97
52W high: $461.62
From 52W high: -11.10%
From 52W low: +60.33%
52W range: 75%
Beta: 0.62

Volume

Rel volume: 0.66×
30D volume: 5.7M
30D $ vol: 2.2B

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.: none
Insider net 3M0 insider-days of buying (no priced lot) and 2 of selling ($661K) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$661K
Insider net 1Y0 insider-days of buying (no priced lot) and 3 of selling ($945K) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$945K

Form 4 transactions by trade date, as filed; latest on file 2026-08-21.

Fundamentals

Sales (ttm): 450.1B2016-06 176.1B2026-06 450.1B+155.6% over the window
Sales/share: $501.482016-06 $184.902026-06 $501.48+171.2% over the window
EPS (ttm): $15.552016-06 $6.392026-06 $15.55+143.4% over the window
FCF (ttm): 23.6B2016-06 8.7B2026-06 23.6B+172.8% over the window
FCF/share: $26.312016-06 $9.092026-06 $26.31+189.5% over the window
Book value/share: $116.442016-06 $38.102026-06 $116.44+205.6% over the window
Net margin: 3.14%2016-06 3.5%2026-06 3.1%-10.6% over the window
ROE: 13.51%2016-06 17.0%2026-06 13.5%-20.7% over the window
ROA: 4.56%2016-06 5.2%2026-06 4.6%-11.8% over the window
Debt / equity: 0.66×2016-06 0.742026-06 0.66-10.1% over the window
Current ratio: 0.782016-06 0.702026-06 0.78+10.5% over the window

Growth (CAGR, ttm) · 10Y

Sales: +6.46%2025-06-30 → 2026-06-30422.8B → 450.1B (+6.5% total)+8.90%2023-06-30 → 2026-06-30348.5B → 450.1B (+29.2% total)+10.59%2021-06-30 → 2026-06-30272.1B → 450.1B (+65.4% total)+9.84%2016-06-30 → 2026-06-30176.1B → 450.1B (+155.6% total)
Net income: -33.71%2025-06-30 → 2026-06-3021.3B → 14.1B (-33.7% total)-12.54%2023-06-30 → 2026-06-3021.1B → 14.1B (-33.1% total)-0.54%2021-06-30 → 2026-06-3014.5B → 14.1B (-2.7% total)+8.62%2016-06-30 → 2026-06-306.2B → 14.1B (+128.5% total)
FCF: -6.55%2025-06-30 → 2026-06-3025.3B → 23.6B (-6.5% total)-14.80%2023-06-30 → 2026-06-3038.2B → 23.6B (-38.2% total)+4.99%2021-06-30 → 2026-06-3018.5B → 23.6B (+27.6% total)+10.56%2016-06-30 → 2026-06-308.7B → 23.6B (+172.8% total)
Shares: -0.89%2025-06-30 → 2026-06-30905.7M → 897.6M (-0.9% total)-1.04%2023-06-30 → 2026-06-30926.3M → 897.6M (-3.1% total)-0.98%2021-06-30 → 2026-06-30942.9M → 897.6M (-4.8% total)-0.59%2016-06-30 → 2026-06-30952.4M → 897.6M (-5.8% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -32.76%2025-06-30 → 2026-06-30$23.12 → $15.55 (-32.7% total)-11.38%2023-06-30 → 2026-06-30$22.35 → $15.55 (-30.4% total)+0.55%2021-06-30 → 2026-06-30$15.13 → $15.55 (+2.8% total)+9.30%2016-06-30 → 2026-06-30$6.39 → $15.55 (+143.4% total)
Sales/share: +7.42%2025-06-30 → 2026-06-30$466.85 → $501.48 (+7.4% total)+10.05%2023-06-30 → 2026-06-30$376.24 → $501.48 (+33.3% total)+11.69%2021-06-30 → 2026-06-30$288.57 → $501.48 (+73.8% total)+10.49%2016-06-30 → 2026-06-30$184.90 → $501.48 (+171.2% total)
FCF/share: -5.71%2025-06-30 → 2026-06-30$27.90 → $26.31 (-5.7% total)-13.91%2023-06-30 → 2026-06-30$41.23 → $26.31 (-36.2% total)+6.03%2021-06-30 → 2026-06-30$19.63 → $26.31 (+34.0% total)+11.22%2016-06-30 → 2026-06-30$9.09 → $26.31 (+189.5% total)
Book value/share: +4.96%2025-06-30 → 2026-06-30$110.93 → $116.44 (+5.0% total)+7.27%2023-06-30 → 2026-06-30$94.32 → $116.44 (+23.5% total)+8.80%2021-06-30 → 2026-06-30$76.38 → $116.44 (+52.4% total)+11.82%2016-06-30 → 2026-06-30$38.10 → $116.44 (+205.6% total)
Dividend/share: +5.17%2025-06-30 → 2026-06-30$8.51 → $8.95 (+5.2% total)+9.43%2023-06-30 → 2026-06-30$6.83 → $8.95 (+31.0% total)+11.47%2021-06-30 → 2026-06-30$5.20 → $8.95 (+72.1% total)+15.47%2016-06-30 → 2026-06-30$2.13 → $8.95 (+321.2% total)
Price: +12.14%2025-10-27 → 2026-10-27$365.98 → $410.39 (+12.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.86%2023-10-27 → 2026-10-27$524.66 → $410.39 (-21.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-1.98%2021-10-27 → 2026-10-27$453.48 → $410.39 (-9.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+11.18%2016-10-26 → 2026-10-27$142.23 → $410.39 (+188.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +15.13%2025-10-27 → 2026-10-27$356.49 → $410.39 (+15.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-5.91%2023-10-27 → 2026-10-27$492.70 → $410.39 (-16.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-0.19%2021-10-27 → 2026-10-27$414.30 → $410.39 (-0.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+13.04%2016-10-26 → 2026-10-27$120.41 → $410.39 (+240.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 26.4×2016-12 23.252026-10 26.10+12.2% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 17.0×2016-12 12.472026-10 17.00+36.3% over the window
Fwd P/E: 18.0×
P/S (ttm)Market cap ÷ TTM revenue.: 0.8×2016-12 0.842026-10 0.82-2.8% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.5×2016-12 4.062026-10 3.53-13.1% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 15.6×2016-12 11.712026-10 15.61+33.3% over the window
EV/EBITDA (fy): 16.2×
EV/Sales (ttm): 0.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.41%2016-09 8.5%2026-06 6.3%-26.2% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 2.26%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 2.21%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $9.28
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 897.6M ÷ 905.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 0.89%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (0.89%) + dividends paid over that year ($8.1B) ÷ market_cap_at(2025-06-30) ($282.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.76%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($1B) ÷ today's market cap ($368.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.28%2016-09 0.5%2026-06 0.3%-44.6% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $1B + TTM dividends $8.1B) ÷ today's market cap ($368.4B). Same caveat as the cash buyback yield.: 2.48%2016-09 1.9%2026-06 2.4%+27.9% over the window

Vs own 10Y history

P/E: 76th
P/OI: 81st
P/S: 14th
P/B: 13th
P/FCF: 27th

Bar = where today’s multiple sits in UNH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-27#

-0.08%

-2.12%

+8.98%

-1.74%

YTD

+24.32%

+12.13%

-9.50%

Recent filings#

Oct 13Earnings · Earnings release — EPS $4.69 vs $4.12 est. (+13.8%) 0.2%
Aug 21Insider sale · Conway Patrick Hugh (Chief Executive Officer, Optum) sold 1,669 shares for $661K on 2 days since Aug 5
Jul 16Earnings · Earnings release — EPS $6.38 vs $4.94 est. (+29.1%); revenue $112.03B (+0% y/y) 1.2%

All filings and insider trades →

Financial statements

Open full UNH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+8.32%	+0.22%
JNJ	Johnson & Johnson	-0.92%	+0.91%
ABBV	AbbVie Inc.	+8.34%	-0.12%
MRK	Merck & Co. Inc.	-4.68%	+0.86%
NVS	Novartis AG	+7.84%	+1.98%
TMO	Thermo Fisher Scientific Inc.	+2.67%	+1.19%
AMGN	Amgen Inc.	+8.04%	+0.75%
GILD	Gilead Sciences Inc.	+5.40%	+0.25%

UNH — UnitedHealth Group Incorporated Common Stock (DE) price, chart and key statistics